Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-07-08
1992-08-25
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514215, 540453, 540455, 540461, 540490, 540521, C07D28536, C07D28538, A61K 3155, A61K 3138
Patent
active
051419300
ABSTRACT:
A fused thiophene compound of the formula: ##STR1## or a pharmaceutically acceptable acid addition salt thereof. In the above formula, one of E.sup.1, E.sup.2 and E.sup.3 is sulfur atom and other two of them are C--R.sup.1 and C--R.sup.2 respectively. R.sup.1 and R.sup.2 are the same or different and each is hydrogen, halogen, nitro, amino, cyano, hydroxyl, formyl, alkyl, alkoxy, haloalkyl, arylalkyl, acyl, alkoxyalkyl, acyloxyalkyl, hydroxyalkyl, acyloxyalkanoyl, alkoxyalkanoyl, hydroxyalkanoyl, aryloxyalkanoyl, haloalkanoyl, alkylthio, alkylsulfinyl, alkylsulfonyl, arylthio, arylsulfinyl, arylsulfonyl, hydroxysulfonyl, halosulfonyl, sulfamoyl, substituted sulfamoyl, carboxyl, acylamino, alkoxycharbonyl, carbamoyl, substituted carbamoyl or substituted amino. D is --CH.sub.2 -- or --S(O).sub.m -- (m is 0, 1 or 2). Q is straight or branched chain alkylene. T is primary amino, secondary amino or tertiary amino. A and B are the same or different and each is carbonyl or thiocarbonyl, or one of A and B is absent and the other of them is carbonyl or thiocarbonyl, or A is --CH.sub.2 -- and B is carbonyl or thiocarbonyl, and n is 1, 2 or 3 with the proviso that n is 2 or 3 when one of A and B is absent and the other of them is carbonyl or thiocarbonyl, and n is 1 or 2 when A and B are other combinations. In the above definitions, (hetero)aromatic ring and heterocyclic ring may optionally be substituted by 1 to 3 substituents. Said compounds have selective affinity for 5-HT.sub.1A receptor, or high affinity for 5-HT.sub.1A and dopamine D.sub.2 receptors so that they are useful as antianxietic drug, antipsychotic drug or drug for the disease of circulatory system. The intermediates for said fused thiophene compounds are also disclosed.
REFERENCES:
patent: 4735940 (1988-04-01), Fischer et al.
patent: 4833142 (1989-05-01), Hartog et al.
patent: 4895841 (1990-01-01), Sugimoto et al.
Chemical Abstracts, vol. 55, 1961, col. 23488.
Chemical Abstracts, vol. 59, 1963, col. 3862.
Chemical Abstracts, vol. 64, 1966, col. 586.
Chemical Abstracts, vol. 69, 1968, 18565x.
Akagi Takeshi
Nakao Tohru
Takehara Shuzo
Tanaka Hiroshi
Yamato Hirotake
Bond Robert T.
Yoshitomi Pharmaceutical Industries Ltd.
LandOfFree
Fused thiophene compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused thiophene compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused thiophene compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-385112